BeStock  
Stocks › Biotechnology › IRON

Disc Medicine IRON

US equityMarket cap rank #2340Biotechnology
$75.14 −$0.97 (-1.27%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $75.14 0.00%
Open$75.20
Prev close$76.11
Day range$74.54 – $77.01
Volume561.6K
Market cap$3.42B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership103.6%-18.57 pts vs. prior quarter
Institutions holding285+9 vs. prior quarter
Insider trades (recent)20 buys / 30 sellsNet selling
Short interest15.46% of floatDays to cover 3.2 · as of 30 Oct 2026
Short-sale volume share12.0%5-day average of daily volume

Short-sale volume as % of daily volume

5%12%19%26%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$2.77M (11 inflow days, 9 outflow days).

Net flow by order size, last 20 sessions

+$1.1MSuper+$1.6MBig+$1.6MMid−$6.5MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 31.6% of shares outstanding.

Largest holders

  • FMR10.55%
  • Access Industries, Inc.6.02%
  • BlackRock5.56%
  • RA Capital Management, L.P.5.38%
  • T. Rowe Price Group, Inc.4.12%
  • J.P. Morgan Asset Management, Inc.4.03%
  • Wellington Management Group3.82%
  • Vestal Point Capital, LP3.40%

By investor type

  • Mutual Fund52.11%
  • VC/PE Fund25.11%
  • Hedge Fund20.94%
  • Private Company3.07%
  • Public Company1.39%
  • Individual/Insider0.48%
  • Government Pension Fund0.28%
  • Endowment Fund0.28%

Reported short interest has fallen from 19.12% to 15.46% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Assenagon Asset Management S.A. Mutual Fund 2026/Q3 +735,300 2.5%
Jane Street Group, LLC Private Company 2026/Q3 +229,219 0.5%
abrdn plc Mutual Fund 2026/Q3 +159,667 1.3%
BNP Paribas Financial Markets SNC Private Company 2026/Q3 +87,806 0.6%
BlackRock Mutual Fund 2026/Q3 +64,964 5.6%
Loomis, Sayles & Company L.P. Mutual Fund 2026/Q3 +58,164 1.0%
Barclays PLC Public Company 2026/Q3 +54,800 0.2%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +53,115 0.1%
Vestal Point Capital, LP Hedge Fund 2026/Q3 +850,000 3.4%
J.P. Morgan Asset Management, Inc. Mutual Fund 2026/Q3 +496,570 4.1%
Opaleye Management Inc. Hedge Fund 2026/Q3 +434,000 1.9%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +326,049 4.1%
Logos Global Management, L.P. Hedge Fund 2026/Q3 +315,000 1.9%
BlackRock Mutual Fund 2026/Q3 +194,068 5.6%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +174,571 1.3%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
9 Nov 2026 William Savage Chief Medical Officer Automatic Disposition -16,035 $85.09 19,178
20 Oct 2026 Atlas Venture Advisors, Inc. Automatic Disposition -41,825 $80.23 1,415,865
14 Sep 2026 John Quisel Chief Executive Officer Derivative Exercise and Retained +36,000 $1.01 114,929
10 Sep 2026 Kevin Bitterman Independent Director Derivative Exercise and Sale -27,136 $70.11 –
3 Sep 2026 Atlas Venture Advisors, Inc. Automatic Disposition -1,689 $79.96 1,457,690
2 Sep 2026 Atlas Venture Advisors, Inc. Automatic Disposition -54,496 $80.98 1,459,379
24 Aug 2026 Jonathan Yu Chief Opearating Officer Derivative Exercise and Sale -9,096 $83.12 10,242
16 Aug 2026 John Quisel Chief Executive Officer Derivative Exercise and Sale -33,000 $79.84 78,929
11 Aug 2026 Jonathan Yu Chief Opearating Officer Derivative Exercise and Sale -804 $82.64 10,242
5 Aug 2026 Rahul Khara Chief Legal Officer Derivative Exercise and Sale -5,000 $80.00 17,324
12 Jul 2026 John Quisel Chief Executive Officer Derivative Exercise and Sale -33,000 $76.05 78,929
6 Jul 2026 Jonathan Yu Chief Opearating Officer Derivative Exercise and Sale -100 $82.50 10,242
28 Jun 2026 Rahul Khara Chief Legal Officer Derivative Exercise and Sale -2,500 $75.00 17,173
25 Jun 2026 Jonathan Yu Chief Opearating Officer Derivative Exercise and Sale -300 $72.50 10,242
21 Jun 2026 Jonathan Yu Chief Opearating Officer Derivative Exercise and Sale -9,700 $72.66 10,242
17 Jun 2026 Georges Gemayel Independent Director Other Derivative Acquisition +6,212 $70.79 6,212
17 Jun 2026 Kevin Bitterman Independent Director Other Derivative Acquisition +6,212 $70.79 6,212
17 Jun 2026 Liam Ratcliffe Independent Director Other Derivative Acquisition +6,212 $70.79 6,212
17 Jun 2026 John Quisel Chief Executive Officer Derivative Exercise and Sale -34,000 $71.61 78,929
17 Jun 2026 Mark Chin Independent Director Other Derivative Acquisition +6,212 $70.79 6,212

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 6,862,594 15.5% 3.2
15 Oct 2026 7,457,523 19.4% 10.6
30 Sep 2026 7,270,420 18.9% 12.8
15 Sep 2026 7,207,702 18.8% 13.6
31 Aug 2026 7,365,002 19.2% 16.6
14 Aug 2026 7,342,568 19.1% 24.8

Discussion

No comments yet — be the first to weigh in on IRON.

Sign in to join the discussion.

Scroll to Top